Global Osteoarthritis Autologous Chondrocyte Therapy Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Osteoarthritis Autologous Chondrocyte Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
  • 1.2.2 2nd Gen C-ACI
  • 1.2.3 3rd Gen M-ACI
• 1.3 Market by Application
  • 1.3.1 Global Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application: 2019 VS 2023 VS 2030
  • 1.3.2 Primary Osteoarthritis
  • 1.3.3 Secondary Osteoarthritis
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Osteoarthritis Autologous Chondrocyte Therapy Market Perspective (2019-2030)
• 2.2 Global Osteoarthritis Autologous Chondrocyte Therapy Growth Trends by Region
  • 2.2.1 Global Osteoarthritis Autologous Chondrocyte Therapy Market Size by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Osteoarthritis Autologous Chondrocyte Therapy Historic Market Size by Region (2019-2024)
  • 2.2.3 Osteoarthritis Autologous Chondrocyte Therapy Forecasted Market Size by Region (2025-2030)
• 2.3 Osteoarthritis Autologous Chondrocyte Therapy Market Dynamics
  • 2.3.1 Osteoarthritis Autologous Chondrocyte Therapy Industry Trends
  • 2.3.2 Osteoarthritis Autologous Chondrocyte Therapy Market Drivers
  • 2.3.3 Osteoarthritis Autologous Chondrocyte Therapy Market Challenges
  • 2.3.4 Osteoarthritis Autologous Chondrocyte Therapy Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Osteoarthritis Autologous Chondrocyte Therapy by Players
  • 3.1.1 Global Osteoarthritis Autologous Chondrocyte Therapy Revenue by Players (2019-2024)
  • 3.1.2 Global Osteoarthritis Autologous Chondrocyte Therapy Revenue Market Share by Players (2019-2024)
• 3.2 Global Osteoarthritis Autologous Chondrocyte Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Osteoarthritis Autologous Chondrocyte Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024
• 3.4 Global Osteoarthritis Autologous Chondrocyte Therapy Market Concentration Ratio
  • 3.4.1 Global Osteoarthritis Autologous Chondrocyte Therapy Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Osteoarthritis Autologous Chondrocyte Therapy Revenue in 2023
• 3.5 Global Key Players of Osteoarthritis Autologous Chondrocyte Therapy Head office and Area Served
• 3.6 Global Key Players of Osteoarthritis Autologous Chondrocyte Therapy, Product and Application
• 3.7 Global Key Players of Osteoarthritis Autologous Chondrocyte Therapy, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Osteoarthritis Autologous Chondrocyte Therapy Breakdown Data by Type

• 4.1 Global Osteoarthritis Autologous Chondrocyte Therapy Historic Market Size by Type (2019-2024)
• 4.2 Global Osteoarthritis Autologous Chondrocyte Therapy Forecasted Market Size by Type (2025-2030)

5 Osteoarthritis Autologous Chondrocyte Therapy Breakdown Data by Application

• 5.1 Global Osteoarthritis Autologous Chondrocyte Therapy Historic Market Size by Application (2019-2024)
• 5.2 Global Osteoarthritis Autologous Chondrocyte Therapy Forecasted Market Size by Application (2025-2030)

6 North America

• 6.1 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size (2019-2030)
• 6.2 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type
  • 6.2.1 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2019-2024)
  • 6.2.2 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2025-2030)
  • 6.2.3 North America Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type (2019-2030)
• 6.3 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application
  • 6.3.1 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2019-2024)
  • 6.3.2 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2025-2030)
  • 6.3.3 North America Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application (2019-2030)
• 6.4 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country
  • 6.4.1 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country: 2019 VS 2023 VS 2030
  • 6.4.2 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2019-2024)
  • 6.4.3 North America Osteoarthritis Autologous Chondrocyte Therapy Market Share by Country (2025-2030)
  • 6.4.4 United States
  • 6.4.5 Canada

7 Europe

• 7.1 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size (2019-2030)
• 7.2 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type
  • 7.2.1 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2019-2024)
  • 7.2.2 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2025-2030)
  • 7.2.3 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type (2019-2030)
• 7.3 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application
  • 7.3.1 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2019-2024)
  • 7.3.2 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2025-2030)
  • 7.3.3 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application (2019-2030)
• 7.4 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country
  • 7.4.1 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country: 2019 VS 2023 VS 2030
  • 7.4.2 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2019-2024)
  • 7.4.3 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2025-2030)
  • 7.4.4 Germany
  • 7.4.5 France
  • 7.4.6 U.K.
  • 7.4.7 Italy
  • 7.4.8 Russia
  • 7.4.9 Nordic Countries

8 China

• 8.1 China Osteoarthritis Autologous Chondrocyte Therapy Market Size (2019-2030)
• 8.2 China Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type
  • 8.2.1 China Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2019-2024)
  • 8.2.2 China Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2025-2030)
  • 8.2.3 China Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type (2019-2030)
• 8.3 China Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application
  • 8.3.1 China Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2019-2024)
  • 8.3.2 China Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2025-2030)
  • 8.3.3 China Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size (2019-2030)
• 9.2 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type
  • 9.2.1 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2019-2024)
  • 9.2.2 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2025-2030)
  • 9.2.3 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type (2019-2030)
• 9.3 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application
  • 9.3.1 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2019-2024)
  • 9.3.2 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2025-2030)
  • 9.3.3 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application (2019-2030)
• 9.4 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Region
  • 9.4.1 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Region: 2019 VS 2023 VS 2030
  • 9.4.2 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Region (2019-2024)
  • 9.4.3 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Region (2025-2030)
  • 9.4.4 Japan
  • 9.4.5 South Korea
  • 9.4.6 China Taiwan
  • 9.4.7 Southeast Asia
  • 9.4.8 India
  • 9.4.9 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Size (2019-2030)
• 10.2 Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2019-2024)
  • 10.2.2 Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2025-2030)
  • 10.2.3 Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type (2019-2030)
• 10.3 Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2019-2024)
  • 10.3.2 Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2025-2030)
  • 10.3.3 Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application (2019-2030)
• 10.4 Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country: 2019 VS 2023 VS 2030
  • 10.4.2 Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2019-2024)
  • 10.4.3 Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2025-2030)
  • 10.4.4 Brazil
  • 10.4.5 Mexico
  • 10.4.6 Turkey
  • 10.4.7 Saudi Arabia
  • 10.4.8 Israel
  • 10.4.9 GCC Countries

11 Key Players Profiles

• 11.1 Vericel
  • 11.1.1 Vericel Company Details
  • 11.1.2 Vericel Business Overview
  • 11.1.3 Vericel Osteoarthritis Autologous Chondrocyte Therapy Introduction
  • 11.1.4 Vericel Revenue in Osteoarthritis Autologous Chondrocyte Therapy Business (2019-2024)
  • 11.1.5 Vericel Recent Development
• 11.2 Japan Tissue Engineering
  • 11.2.1 Japan Tissue Engineering Company Details
  • 11.2.2 Japan Tissue Engineering Business Overview
  • 11.2.3 Japan Tissue Engineering Osteoarthritis Autologous Chondrocyte Therapy Introduction
  • 11.2.4 Japan Tissue Engineering Revenue in Osteoarthritis Autologous Chondrocyte Therapy Business (2019-2024)
  • 11.2.5 Japan Tissue Engineering Recent Development
• 11.3 Orthocell
  • 11.3.1 Orthocell Company Details
  • 11.3.2 Orthocell Business Overview
  • 11.3.3 Orthocell Osteoarthritis Autologous Chondrocyte Therapy Introduction
  • 11.3.4 Orthocell Revenue in Osteoarthritis Autologous Chondrocyte Therapy Business (2019-2024)
  • 11.3.5 Orthocell Recent Development
• 11.4 CO.DON GmbH
  • 11.4.1 CO.DON GmbH Company Details
  • 11.4.2 CO.DON GmbH Business Overview
  • 11.4.3 CO.DON GmbH Osteoarthritis Autologous Chondrocyte Therapy Introduction
  • 11.4.4 CO.DON GmbH Revenue in Osteoarthritis Autologous Chondrocyte Therapy Business (2019-2024)
  • 11.4.5 CO.DON GmbH Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer

List of Tables

Table 1. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of 2nd Gen C-ACI

Table 3. Key Players of 3rd Gen M-ACI

Table 4. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Osteoarthritis Autologous Chondrocyte Therapy Market Share by Region (2019-2024)

Table 8. Global Osteoarthritis Autologous Chondrocyte Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Osteoarthritis Autologous Chondrocyte Therapy Market Share by Region (2025-2030)

Table 10. Osteoarthritis Autologous Chondrocyte Therapy Market Trends

Table 11. Osteoarthritis Autologous Chondrocyte Therapy Market Drivers

Table 12. Osteoarthritis Autologous Chondrocyte Therapy Market Challenges

Table 13. Osteoarthritis Autologous Chondrocyte Therapy Market Restraints

Table 14. Global Osteoarthritis Autologous Chondrocyte Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Osteoarthritis Autologous Chondrocyte Therapy Market Share by Players (2019-2024)

Table 16. Global Top Osteoarthritis Autologous Chondrocyte Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Autologous Chondrocyte Therapy as of 2023)

Table 17. Global Osteoarthritis Autologous Chondrocyte Therapy Industry Ranking 2022 VS 2023

Table 18. Global 5 Largest Players Market Share by Osteoarthritis Autologous Chondrocyte Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Osteoarthritis Autologous Chondrocyte Therapy, Headquarters and Area Served

Table 20. Global Key Players of Osteoarthritis Autologous Chondrocyte Therapy, Product and Application

Table 21. Global Key Players of Osteoarthritis Autologous Chondrocyte Therapy, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Osteoarthritis Autologous Chondrocyte Therapy Revenue Market Share by Type (2019-2024)

Table 25. Global Osteoarthritis Autologous Chondrocyte Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Osteoarthritis Autologous Chondrocyte Therapy Revenue Market Share by Type (2025-2030)

Table 27. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Osteoarthritis Autologous Chondrocyte Therapy Revenue Market Share by Application (2019-2024)

Table 29. Global Osteoarthritis Autologous Chondrocyte Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Osteoarthritis Autologous Chondrocyte Therapy Revenue Market Share by Application (2025-2030)

Table 31. North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Osteoarthritis Autologous Chondrocyte Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Osteoarthritis Autologous Chondrocyte Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Osteoarthritis Autologous Chondrocyte Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 63. Vericel Company Details

Table 64. Vericel Business Overview

Table 65. Vericel Osteoarthritis Autologous Chondrocyte Therapy Product

Table 66. Vericel Revenue in Osteoarthritis Autologous Chondrocyte Therapy Business (2019-2024) & (US$ Million)

Table 67. Vericel Recent Development

Table 68. Japan Tissue Engineering Company Details

Table 69. Japan Tissue Engineering Business Overview

Table 70. Japan Tissue Engineering Osteoarthritis Autologous Chondrocyte Therapy Product

Table 71. Japan Tissue Engineering Revenue in Osteoarthritis Autologous Chondrocyte Therapy Business (2019-2024) & (US$ Million)

Table 72. Japan Tissue Engineering Recent Development

Table 73. Orthocell Company Details

Table 74. Orthocell Business Overview

Table 75. Orthocell Osteoarthritis Autologous Chondrocyte Therapy Product

Table 76. Orthocell Revenue in Osteoarthritis Autologous Chondrocyte Therapy Business (2019-2024) & (US$ Million)

Table 77. Orthocell Recent Development

Table 78. CO.DON GmbH Company Details

Table 79. CO.DON GmbH Business Overview

Table 80. CO.DON GmbH Osteoarthritis Autologous Chondrocyte Therapy Product

Table 81. CO.DON GmbH Revenue in Osteoarthritis Autologous Chondrocyte Therapy Business (2019-2024) & (US$ Million)

Table 82. CO.DON GmbH Recent Development

Table 83. Research Programs/Design for This Report

Table 84. Key Data Information from Secondary Sources

Table 85. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type: 2023 VS 2030

Figure 3. 2nd Gen C-ACI Features

Figure 4. 3rd Gen M-ACI Features

Figure 5. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application: 2023 VS 2030

Figure 7. Primary Osteoarthritis Case Studies

Figure 8. Secondary Osteoarthritis Case Studies

Figure 9. Osteoarthritis Autologous Chondrocyte Therapy Report Years Considered

Figure 10. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Osteoarthritis Autologous Chondrocyte Therapy Market Share by Region: 2023 VS 2030

Figure 13. Global Osteoarthritis Autologous Chondrocyte Therapy Market Share by Players in 2023

Figure 14. Global Top Osteoarthritis Autologous Chondrocyte Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Autologous Chondrocyte Therapy as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by Osteoarthritis Autologous Chondrocyte Therapy Revenue in 2023

Figure 16. North America Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type (2019-2030)

Figure 18. North America Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application (2019-2030)

Figure 19. North America Osteoarthritis Autologous Chondrocyte Therapy Market Share by Country (2019-2030)

Figure 20. United States Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type (2019-2030)

Figure 24. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application (2019-2030)

Figure 25. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Share by Country (2019-2030)

Figure 26. Germany Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. China Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type (2019-2030)

Figure 34. China Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application (2019-2030)

Figure 35. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type (2019-2030)

Figure 37. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application (2019-2030)

Figure 38. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Share by Region (2019-2030)

Figure 39. Japan Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. South Korea Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. China Taiwan Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Southeast Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. India Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Australia Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type (2019-2030)

Figure 47. Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application (2019-2030)

Figure 48. Middle East, Africa, and Latin America Osteoarthritis Autologous Chondrocyte Therapy Market Share by Country (2019-2030)

Figure 49. Brazil Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Mexico Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Turkey Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Israel Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. GCC Countries Osteoarthritis Autologous Chondrocyte Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Vericel Revenue Growth Rate in Osteoarthritis Autologous Chondrocyte Therapy Business (2019-2024)

Figure 56. Japan Tissue Engineering Revenue Growth Rate in Osteoarthritis Autologous Chondrocyte Therapy Business (2019-2024)

Figure 57. Orthocell Revenue Growth Rate in Osteoarthritis Autologous Chondrocyte Therapy Business (2019-2024)

Figure 58. CO.DON GmbH Revenue Growth Rate in Osteoarthritis Autologous Chondrocyte Therapy Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed